Text this: Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

 __   __   __   __    _  _      ___      _____   
 \ \\/ //  \ \\/ //  | \| ||   / _ \\   /  ___|| 
  \   //    \ ` //   |  ' ||  | / \ || | // __   
  / . \\     | ||    | .  ||  | \_/ || | \\_\ || 
 /_//\_\\    |_||    |_|\_||   \___//   \____//  
 `-`  --`    `-`'    `-` -`    `---`     `---`